Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil

This publication has 9 references indexed in Scilit:

• Phase I and pharmacokinetic study of D-verapamil and doxorubicin
  British Journal of Cancer, 1991
• The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecific
  Biochemical Pharmacology, 1990
• Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil
  British Journal of Cancer, 1989
• High-performance liquid chromatographic determination of adriblastin in human plasma, urine, saliva and liver punctuate by column switching for drug monitoring studies
  Journal of Chromatography B: Biomedical Sciences and Applications, 1988
• Multiple-Drug Resistance in Human Cancer
  New England Journal of Medicine, 1987
• The effect of verapamil on the pharmacokinetics of adriamycin
  Cancer Chemotherapy and Pharmacology, 1986
• The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans
  American Heart Journal, 1985
• Stereoselective first‐pass metabolism of highly cleared drugs: studies of the bioavailability of L‐ and D‐verapamil examined with a stable isotope technique.
  British Journal of Clinical Pharmacology, 1984
• Pharmacokinetics of (+)‐, (‐)‐ and (+/‐)‐verapamil after intravenous administration.
  British Journal of Clinical Pharmacology, 1984